Literature DB >> 20538744

Reductions in risk factors for secondary prevention of coronary heart disease by ethnic group in south-west London: 10-year longitudinal study (1998-2007).

Joanna Murray1, Sonia Saxena, Christopher Millett, Vasa Curcin, Simon de Lusignan, Azeem Majeed.   

Abstract

OBJECTIVES: To explore trends by ethnicity in clinical risk factor recording and control among patients with coronary heart disease (CHD), during a period of major investment in quality improvement initiatives in general practice in England.
DESIGN: Longitudinal study from 1998 to 2007, using general practice data extracted from electronic patient records of all adult patients (n=177,412) registered in 2007.
SETTING: Twenty-nine general practices in Wandsworth south-west London.
SUBJECTS: Three thousand two hundred registered patients with a recorded diagnosis of CHD, in 2007. MAIN OUTCOME MEASURES: Mean systolic and diastolic blood pressure and mean cholesterol of patients with CHD, for each calendar year.
RESULTS: From 1998 to 2007, the proportion of patients with CHD who had their blood pressure recorded rose from 33.2% to 93.9% and cholesterol from 21.7% to 83.5%. Over this period, mean blood pressure decreased from 140/80 to 133/74 mmHg (P<0.001). There was a reduction in mean cholesterol from 5.2 to 4.3 mmol/l (P<0.001). Reductions in mean blood pressure and cholesterol occurred across all ethnic groups.
CONCLUSIONS: From 1998 to 2007, risk factor control among patients with CHD improved, with reductions in their mean blood pressure and cholesterol across all ethnic groups. Widespread policy change has helped to improve the quality and equity of primary care for heart disease patients. Health improvements predated implementation of the Quality and Outcomes Framework and have since continued. Our findings illustrate how a national health care system with universal coverage can significantly reduce inequalities and improve chronic disease care for all ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538744     DOI: 10.1093/fampra/cmq030

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

1.  Confidence and quality in managing CKD compared with other cardiovascular diseases and diabetes mellitus: a linked study of questionnaire and routine primary care data.

Authors:  Mohammad A Tahir; Olga Dmitrieva; Simon de Lusignan; Jeremy van Vlymen; Tom Chan; Ramez Golmohamad; Kevin Harris; Charles Tomson; Nicola Thomas; Hugh Gallagher
Journal:  BMC Fam Pract       Date:  2011-08-05       Impact factor: 2.497

2.  Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).

Authors:  Paramjit S Gill; Melanie Calvert; Russell Davis; Michael K Davies; Nick Freemantle; Gregory Y H Lip
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

3.  Population health status of South Asian and African-Caribbean communities in the United Kingdom.

Authors:  Melanie Calvert; Helen Duffy; Nick Freemantle; Russell Davis; Gregory Y H Lip; Paramjit Gill
Journal:  BMC Health Serv Res       Date:  2012-04-25       Impact factor: 2.655

4.  Improving Osteoporosis Management in Primary Care: An Audit of the Impact of a Community Based Fracture Liaison Nurse.

Authors:  Tom Chan; Simon de Lusignan; Alun Cooper; Mary Elliott
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

5.  What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial.

Authors:  Akin Nihat; Simon de Lusignan; Nicola Thomas; Mohammad Aumran Tahir; Hugh Gallagher
Journal:  BMJ Open       Date:  2016-04-06       Impact factor: 2.692

Review 6.  The impact of reimbursement systems on equity in access and quality of primary care: A systematic literature review.

Authors:  Wenjing Tao; Janne Agerholm; Bo Burström
Journal:  BMC Health Serv Res       Date:  2016-10-04       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.